Pulling SEC filings + quote and writing the call…

QCR HOLDINGS INC
Next earnings Jul 21, 2026 · consensus $1.97 EPS, $93.5M rev
Last earnings -1.6% on 2026-04-22
Steady community-bank compounder growing EPS ~12% at a fair 12.9x P/E and ~1.45x book — own it, but no margin of safety to chase.
Diluted EPS (FY2025) $7.49 · FY2025
Middling fundamentals offset by an attractive price (~194% below fair value) — worth a look on the value angle.
QCR Holdings is a well-run, four-bank Midwest holding company (Iowa/Illinois/Missouri) delivering exactly what you want from a community bank: consistent, profitable growth. Net income has climbed every year — $98.9M (2021) → $99.1M (2022) → $114M (2023) → $114M (2024) → $127M (2025) — and FY2025 EPS of $7.49 grew 11.6%, helped by a ~1% share-count reduction that signals buybacks rather than dilution. The balance sheet is sound for the model: $9.58B assets, $1.11B equity (+11.5%), and retained earnings up 16.3% to $773M show real internal capital generation. Liabilities/equity of 7.61x looks heavy only to those unfamiliar with banks — it is normal leverage funded by deposits, not stressed wholesale debt (current debt is a trivial $2.65M).
The quality is solid but not exceptional, which is what caps this at a hold. ROE of 11.4% is respectable but below the 13–15% that earns a premium multiple, and at $96.64 the stock trades at roughly 1.45x book value (equity $1.11B / 16.7M shares ≈ $66.5 book). A 12.9x P/E on a low-teens grower is a fair, PEG-near-1 price — neither cheap enough to back the truck up nor expensive enough to flee. Note: the revenue line (and the derived P/S of 3.0 and 23.3% net margin) rests on an inconsistent XBRL tag — the +46.3% 'growth' and the missing FY2024/2025 figures are tagging artifacts, not real, so I anchor the valuation on EPS, net income, ROE and book value, which are clean.
AI-generated analysis, produced by our proprietary engine from SEC filing data.
Investment recommendation produced by TENK/calls (tenkcalls.com), Luxembourg. Completed Jun 30, 2026, 5:41 AM ET. Ratings & methodology: definitions · All recommendations to date: track record · Conflicts: disclosures. Not investment advice.
| Line item | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Revenue | $301M | $373M | $546M | — | — |
| Gross profit | — | — | — | — | — |
| Operating income | — | — | — | — | — |
| Net income | $98.9M | $99.1M | $114M | $114M | $127M |
| Diluted EPS | $6.20 | $5.87 | $6.73 | $6.71 | $7.49 |
| Net margin | 32.9% | 26.5% | 20.8% | — | — |
Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.
Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.
Annual meeting vote: directors elected, auditor ratified, say-on-pay passed
Q1 2026 (period 3/31): equity continues building, no flagged deterioration
Released Q1 2026 earnings results
Released Q1 2026 earnings results
2026 proxy: routine board/auditor/pay items for annual meeting
FY2025 record: NI $127M (+12%), EPS $7.49, equity $1.11B (+12%), ROE 11.4%
Other-events disclosure (likely dividend/capital action), no material change
FY2025 results: record net income $127M (+12%), diluted EPS $7.49
FY2025 results: record net income $127M (+12%), diluted EPS $7.49
Sources: SEC EDGAR (CIK 0000906465, latest 10-Q filed 2026-05-08) · EODHD · Proprietary analysis · as of 6/30/2026, 9:41:08 AM.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.
Last 90 days: 2 open-market buys · 2 sales
| 2026-06-09 | Ekizian Laura L President & CEO, QCBT | Exercise | 750.00 @ $45.00 | $33.8K |
| 2026-06-09 | Ekizian Laura L President & CEO, QCBT | Sell | 750.00 @ $94.96 | $71.2K |
| 2026-06-02 | Reasner Amy L Director | Buy | 60.00 @ $90.25 | $5.42K |
| 2026-06-02 | Klein James D. President, CRBT | Exercise | 94.00 @ $66.52 | $6.25K |
| 2026-06-01 | Lee Nicole A EVP, Chief HR Officer | Exercise | 234.00 @ $38.81 | $9.08K |
| 2026-04-30 | Klein James D. President, CRBT | Sell | 310.00 @ $91.00 | $28.2K |
| 2026-04-23 | Reasner Amy L Director | Buy | 100.00 @ $88.35 | $8.84K |
| 2026-03-02 | Field James Matthew Director | Award | 387.00 @ $87.99 | $34.1K |
| 2025-05-12 | Klein James D. President, CRBT | Sell | 428.00 @ $60.74 | $26.0K |
Source: EODHD. Yield = trailing-12-month dividends ÷ price.
Dates from 8-K (Item 2.02); beat/miss = reported EPS vs consensus (Finnhub, recent quarters); move = prior close → close on/after.
Disclosed under the STOCK Act
Self-reported periodic transaction reports (STOCK Act). Amounts are disclosed ranges; a trade may be a spouse's. Disclosures lag the trade by up to ~45 days. Source: House Clerk + Senate eFD.
1195 tracked peers · median
Recent news tone vs the market's typical (which skews positive). A soft signal, not a recommendation.